The modern landscape of neurodegenerative therapeutics is defined by an urgent quest for disease-modifying interventions capable of altering the destructive trajectory of progressive motor disorders. Among these conditions, Parkinson’s disease stands out as a complex pathology driven by the selective degeneration and loss of dopamine-producing neurons within the substantia nigra pars compacta, leading to debilitating […]
The global search for disease-modifying treatments capable of halting or reversing neurodegenerative conditions stands as one of the most demanding challenges in contemporary biomedicine. Among these complex pathologies, Alzheimer’s disease represents a devastating progressive disorder characterized by extensive synaptic loss, chronic neuroinflammation, abnormal protein aggregation, and the steady deterioration of cognitive function. While conventional pharmaceutical […]